Why devices are failing in oncology drug delivery applications
Some traditional polymers used in drug delivery devices are not compatible with modern oncology chemotherapies—including the cancer drugs and the carrier solvents that help make them effective.
Device manufacturers have more reasons than ever to understand the chemical resistance of the materials they use in devices, including:
• The widespread use and growing economic importance of oncology drugs
• A recent FDA Safety Alert* concerning infusion devices made with polycarbonate (PC) or acrylonitrile-butadiene-styrene (ABS)